Profil
Colin Kealey currently works at NeuroSigma, Inc., as President, Chief Executive Officer & Director from 2022 and Monarch Biosciences, Inc., as Chief Executive Officer & Secretary.
Dr. Kealey received his undergraduate degree from the University of Wisconsin and doctorate degree from the University of Iowa Carver College of Medicine.
Postes actifs de Colin Kealey
| Sociétés | Poste | Début |
|---|---|---|
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology Develops and commercializes trigeminal nerve stimulation for a variety of neurologic and psychiatric disorders | Directeur Général | - |
Monarch Biosciences, Inc.
Monarch Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops medical device and biotechnology products | Directeur Général | - |
Formation de Colin Kealey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
NeuroSigma, Inc.
NeuroSigma, Inc. Medical SpecialtiesHealth Technology Develops and commercializes trigeminal nerve stimulation for a variety of neurologic and psychiatric disorders | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa Carver College of Medicine
University of Iowa Carver College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monarch Biosciences, Inc.
Monarch Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops medical device and biotechnology products | Electronic Technology |
















